Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Repeated Ketamine Treatment to Accelerate Efficacy of Prolonged Exposure in PTSD

To see complete record on, please visit this link

Id: NCT04560660

Organisation Name: VA Office of Research and Development

Overal Status: Recruiting

Start Date: March 9, 2021

Last Update: June 1, 2022

Lead Sponsor: VA Office of Research and Development

Brief Summary: The purpose of this study is to test the safety and efficacy of repeated doses of ketamine as compared to placebo to reduce symptoms of Posttraumatic Stress Disorder (PTSD) among Veteran receiving Prolonged Exposure Therapy.

  • PTSD

Total execution time in seconds: 0.30513501167297